Lyons Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Lyons Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,241	Closed	-$60K	–	59
2016 Q4	$60K	Hold	4,241	–	–	0.08%	45
2016 Q3	$74K	Hold	4,241	–	–	0.1%	47
2016 Q2	$73K	Hold	4,241	–	–	0.11%	43
2016 Q1	$84K	Sell	4,241 -1,426	-25%	-$22.9K	0.12%	44
2015 Q4	$109K	Hold	5,667	–	–	0.14%	52
2015 Q3	$110K	Hold	5,667	–	–	0.14%	49
2015 Q2	$264K	Sell	5,667 -11	-0.2%	-$477	0.3%	44
2015 Q1	$248K	Hold	5,678	–	–	0.27%	44
2014 Q4	$196K	Hold	5,678	–	–	0.21%	47
2014 Q3	$238K	Hold	5,678	–	–	0.25%	51
2014 Q2	$334K	Hold	5,678	–	–	0.3%	50
2014 Q1	$359K	Hold	5,678	–	–	0.31%	47
2013 Q4	$334K	Hold	5,678	–	–	0.31%	44
2013 Q3	$299K	Sell	5,678 -500	-8%	-$33.6K	0.27%	48
2013 Q2	$478K	Buy	+6,178	New	+$504K	0.48%	20

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lyons Wealth Management's ARNA Position: Q1 2017 in Review

Lyons Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2017, closing a stake of 4,241 shares — an estimated $60K sold.

Lyons Wealth Management first reported a position in ARNA in Q2 2013 and held it in 15 quarters. The position peaked at $478K in Q2 2013. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

Lyons Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Lyons Wealth Management sold 4,241 Arena Pharmaceuticals Inc shares in Q1 2017, an estimated $60K.
Lyons Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Lyons Wealth Management's Arena Pharmaceuticals Inc position peaked at $478K in Q2 2013.
126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on Lyons Wealth Management's 13F filing for Q1 2017, filed 15 May 2017.